Phase 4 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with type 2 diabetes within the last 5 years
- You are willing to take part, understand what the trial involves, and are happy to sign a consent form and follow all study requirements
- Your blood sugar is managed either through diet and exercise alone, or you have been on one or two diabetes medications (from a specific approved list) at a stable dose for at least 8 weeks
- Your HbA1c (a measure of average blood sugar over roughly 3 months) is between 7.0% and 8.5%
- You have also been diagnosed with non-alcoholic fatty liver disease (a condition where fat builds up in the liver, not caused by alcohol)
Who may not be able to join:
- You have type 1 diabetes, diabetes related to pregnancy, or another specific type of diabetes
- You have had a serious diabetes complication in the past 6 months, such as dangerously high blood sugar requiring emergency care
- You have had serious eye, nerve, circulation, or foot problems related to diabetes in the past 6 months
- You have serious liver disease, advanced kidney disease, or other significant conditions such as pancreatitis or liver cirrhosis
- You had a heart attack, unstable chest pain, stroke, or a major heart procedure in the past 6 months, or you have advanced heart failure or a life-threatening irregular heartbeat
- You have had a bleeding or blockage stroke in the past 6 months that researchers feel makes participation unsuitable
- You have high blood pressure that is not well controlled (readings at or above 160/100 mmHg)
- You have a hormonal condition (other than diabetes) that affects your weight, blood sugar, or fats in the blood, such as an overactive thyroid or Cushing's syndrome
- You have been diagnosed with a cancer (other than a treated skin basal cell carcinoma) in the past 5 years
- You have had a serious infection, major injury, or major surgery in the past 3 months
- You have a history of substance or drug misuse in the past 5 years
- You have taken part in another clinical drug or device trial in the past 3 months
- You have severe anaemia or need regular blood transfusions
- You have taken medications that affect your weight (such as water tablets or weight-loss drugs) in the past 90 days
- You have taken medications that significantly affect blood sugar for more than 1 week in the past 12 weeks (such as steroid tablets, growth hormone, or certain antipsychotic medications) — note that low-dose blood pressure water tablets may be allowed (confirm with trial site)
- You have had weight-loss (bariatric) surgery or are planning to have it
- Your liver enzyme levels (ALT/AST) are more than 5 times higher than the normal upper limit
- Your kidney filtering function is significantly reduced (eGFR below 40, measured by a specific formula)
- You are currently pregnant, breastfeeding, or planning to become pregnant
- You have a history of hepatitis B, hepatitis C, tuberculosis, HIV, or syphilis
- You have taken certain liver-related treatments (such as vitamin E, ursodeoxycholic acid, or similar drugs) within the past 3 months
- You have a structural or functional problem with your urinary or reproductive system that makes infections more likely
- You have a blood or red blood cell disorder
- You have taken immune-suppressing medications such as cyclosporine or cyclophosphamide
- You have metal implants or devices in your body that are not compatible with MRI scanning
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hong Chen, MD, Zhujiang Hospital
Phone: 13602759769
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The difference of liver fat content (magnetic resonance imaging proton density fat fraction,MRI-PDFF)) between the subjects and the control group.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.